Dr. Huiwang Ai's lab at the University of Virginia focuses on developing advanced imaging techniques to study neurological disorders like Alzheimer's disease. The lab creates genetically encoded fluorescent indicators to visualize oxidative stress and synaptic zinc dynamics in real-time within brain tissues. This research aims to improve our understanding of the mechanisms underlying these disorders, potentially leading to new therapeutic approaches.

Dr. Gary K Owens' research lab focuses on understanding atherosclerosis, a serious disease that causes heart attacks and strokes. The lab investigates how inflammation and metabolic issues, such as insulin resistance, influence the development and progression of atherosclerosis. By studying specific signaling pathways and cell types involved in this disease, the lab aims to develop more effective treatments that enhance heart health without compromising the immune system.

Dr. Ming-Feng Tsai's lab at the University of Virginia focuses on understanding how mitochondrial calcium transport proteins function. These proteins are crucial for many processes in cells, including energy production and cell death. By studying their molecular mechanisms, the lab aims to uncover how these proteins can be targeted for new therapies to treat conditions like heart failure and neurodegenerative diseases.

Jochen Zimmer's lab at the University of Virginia studies complex carbohydrates produced by bacteria, particularly focusing on how these essential molecules are synthesized and assembled on the bacterial surface. The lab's research is important for understanding bacterial behavior, especially in the context of infections caused by biofilms, which are sticky clusters of bacteria that can be difficult to treat. By using advanced techniques in structural biology and biochemistry, the team aims to unlock the mechanisms that enable these carbohydrates to provide protection and support to bacteria, which may lead to new strategies for developing drugs or biomaterials.

Anne K. Kenworthy's lab focuses on understanding caveolins, unique proteins that influence how cells function by shaping their membranes. The research investigates how these proteins contribute to cellular processes like metabolism and cardiovascular health, especially in contexts where they malfunction. By employing advanced techniques like cryo-electron microscopy, the lab aims to unravel the mysteries of caveolin structure and function, which may provide insights into various diseases such as cancer and muscular dystrophy.

Professor Ilya Levental's lab at the University of Virginia is focused on understanding the structure and function of cell membranes, specifically how the composition of lipids impacts cell signaling and behavior. The lab investigates the organization of proteins and lipids in T-cells, aiming to uncover how these structures influence immune responses. Overall, the research aims to shed light on how membrane organization affects cell physiology and may inform treatments for diseases related to membrane dysfunction, like cancer and cardiovascular diseases.

Dr. Ling Qi's lab at the University of Virginia focuses on the role of a protein complex known as SEL1L-HRD1 in various health-related processes. The lab investigates how this complex helps to degrade misfolded proteins in our cells, affecting conditions such as Alzheimer's disease and liver diseases. Their work sheds light on how genetic mutations may disrupt this important degradation pathway and contribute to disease.

John Hackett Bushweller's lab focuses on developing new treatments for prostate cancer, particularly by designing small molecule inhibitors that target the ERG transcription factor, which plays a crucial role in the development and progression of this disease. The research aims to enhance the effectiveness of existing therapies and address the problem of drug resistance in patients. Through biochemical and cellular assays, the lab seeks to optimize these inhibitors and evaluate their effects on cancer biology, potentially leading to improved patient outcomes.

Dr. Brant Isakson's lab at the University of Virginia focuses on understanding the mechanisms that regulate blood pressure and vascular health, particularly through the actions of specific proteins in the kidneys and blood vessels. Their research investigates how renin, a key hormone in blood pressure regulation, is released and how inflammation affects the barrier function of blood vessels, especially during conditions like sepsis. By exploring the interactions between different proteins, the lab aims to find potential therapeutic targets for hypertension and other cardiovascular diseases.

Dr. Swapnil K. Sonkusare's lab at the University of Virginia focuses on understanding how calcium signaling in blood vessels affects blood pressure regulation, particularly under conditions like hypertension. They explore specific mechanisms in smooth muscle and endothelial cells that influence blood vessel dilation and constriction, which can help identify potential treatments for high blood pressure. Their research may lead to novel therapies aimed at improving vascular health and lowering cardiovascular risks.